公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 FRESENIUS KABI BRASIL LTDA取消

98 记录

产品持有公司班级有效性
Equipo para bomba optima MS ou módulo MVP sem DEHP80145119032FRESENIUS KABI BRASIL LTDAII现有
Extensor Injectomat Line PVC SEM DEHP80145119035FRESENIUS KABI BRASIL LTDAII现有
Extensor PCA80145119036FRESENIUS KABI BRASIL LTDAII现有
Extensor SL - PUR80145110253FRESENIUS KABI BRASIL LTDAI现有
Extensor SL - PVC80145110254FRESENIUS KABI BRASIL LTDAI现有
Extensor SL - fotoprotetor80145110252FRESENIUS KABI BRASIL LTDAI现有
Extensor para Equipo Enteral Applix80145119011FRESENIUS KABI BRASIL LTDAII现有
Extensores ProNeo - ENFit80145110250FRESENIUS KABI BRASIL LTDAII现有
FAMÍLIA DE BOMBAS AGILIA VP80145110241FRESENIUS KABI BRASIL LTDAIII02/07/2028
FREKA FCJ FR 9 ENFit80145110262FRESENIUS KABI BRASIL LTDAIII08/09/2030
FREKA PAED CH 6,510004100147FRESENIUS KABI BRASIL LTDAII现有
FREKA PEXACT SET II CH/FR 1580145110187FRESENIUS KABI BRASIL LTDAIII07/07/2028
FREKA SONDA ENTERAL CH 1510004100145FRESENIUS KABI BRASIL LTDAII现有
FREKA TUBO INTESTINAL CH 12 PARA FREKA PEG CH 20 ENFit80145110258FRESENIUS KABI BRASIL LTDAIII24/08/2030
FREKA TUBO INTESTINAL CH 9 PARA FREKA PEG CH 15 ENFit80145110257FRESENIUS KABI BRASIL LTDAIII24/08/2030
FREKA-SONDA ENTERAL10004100022FRESENIUS KABI BRASIL LTDAII现有
Família DiaSpect Control HBT80145110230FRESENIUS KABI BRASIL LTDAII现有
Família de Bombas Agilia SP80145110240FRESENIUS KABI BRASIL LTDAIII05/02/2028
Filtro para Hemocomponentes com penetrador ventilado e conector luer80145119018FRESENIUS KABI BRASIL LTDAII现有
Freka Belly Button Basic Kit80145110263FRESENIUS KABI BRASIL LTDAIII08/09/2030
Freka Belly Button Comfort Kit ENFit80145110273FRESENIUS KABI BRASIL LTDAIII16/11/2031
Freka Belly Button Comfort Paed ENFit80145110274FRESENIUS KABI BRASIL LTDAIII16/11/2031
Freka Button Extension Set 1 - ENFit80145119022FRESENIUS KABI BRASIL LTDAII现有
Freka Connect ENLock80145110236FRESENIUS KABI BRASIL LTDAII现有
Freka Extensor, 30 cm80145119015FRESENIUS KABI BRASIL LTDAII现有

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家